BioLineRx News, BioLineRx Quote, BLRX Quote

BioLineRx (NQ:BLRX) Delayed: 0.58 -0.03 (4.92%)

Prev. Close

$0.61

Open

$0.62

52 Wk High

$1.63

52 Wk Low

$0.71

Day High

$0.62

Day Low

$0.56

P/E

N/A

EPS

$0.00

Volume

636,134

Friends, Peers and Foes (?): CADL, IMRX, ONCY YP2A.F (more...)

Apr 17, 2024 07:12 AM Form 6-K BioLineRx Ltd. For: Apr 17
Apr 17, 2024 07:00 AM BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting
Apr 10, 2024 07:25 AM Form 6-K BioLineRx Ltd. For: Apr 10
Apr 10, 2024 07:06 AM BioLineRx (BLRX) Accesses Second Tranche of $20 Million Under Previously Announced $40 Million Non-Dilutive Debt Financing Agreement
Apr 10, 2024 07:00 AM BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40 Million Non-Dilutive Debt Financing Agreement
Apr 1, 2024 10:35 AM Form 6-K BioLineRx Ltd. For: Apr 01
Apr 1, 2024 10:31 AM Form 424B5 BioLineRx Ltd.
Apr 1, 2024 09:01 AM BioLineRx (BLRX) Announces 7.5M Share Offering at $0.80/sh
Apr 1, 2024 09:00 AM BioLineRx Announces $6 Million Registered Direct Offering
Mar 26, 2024 04:58 PM Form 20-F/A BioLineRx Ltd. For: Dec 31

Entities mentioned with BLRX